Background Responses to the systemic treatments commonly used to treat psoriasis vary.
Biomarkers that accurately predict effectiveness and safety would enable targeted treatment …

Background Formation of anti-drug antibodies (ADAs) against biologics is an important
cause of psoriasis treatment failure. Objective This study aimed to summarize the …

Introduction Treatment with biologics often leads to clearance of psoriasis. However, some
patients do repeatedly fail to respond and/or lose an achieved response (treatment …

Epidemiological data demonstrate strong associations between psoriasis and metabolic
comorbidities, including obesity, hypertension, diabetes mellitus, dyslipidemia, and non …

Psoriasis patients are at increased risk of harmful alcohol use and alcohol dependency with
many deleterious effects. Increasing alcohol use is associated with worsening psoriasis …

Factors such as obesity, alcohol consumption, and tobacco use are associated with both
increased psoriasis severity and inadequate response to systemic and biologic therapies …

METHODS: Among 100 patients, 75 met the inclusion criteria, and 62 were matched by
propensity score. We evaluated time to treatment escalation as the primary outcome and …

Psoriasis is a chronic disease that has no definitive cure. In this review study, the main
sources of Persian Medicine (PM) such as the Canon of Medicine (by Avicenna) and Al-Havi …

Purpose SUPREME, a phase IIIb study conducted in Italy, demonstrated safety and high
efficacy of secukinumab for up to 72 weeks in patients with moderate-to-severe plaque-type …

Аннотация Пациенты детского возраста, страдающие псориазом, для поддержания
долговременной ремиссии, как правило, нуждаются в длительной терапии генно …